Vardenafil and methylarginines in pulmonary hypertension

Vardenafil and methylarginines in pulmonary hypertension

Background: Pulmonary hypertension (PH) is a rare condition characterized by endothelial dysfunction and vascular remodelling, leading to increased pulmonary vascular resistance (PVR) and right ventricular heart failure. Endothelial dysfunction is associated with an imbalance between vasoconstrictor...

Full description

Bibliographic Details
Main Author: Sandqvist, Anna
Format: Doctoral Thesis
Language:English
Published: Umeå universitet, Klinisk farmakologi 2016
Subjects:
vardenafil
pulmonary hypertension
pharmacokinetics
haemodynamics
right heart catheterization
adenosine
dimethylarginines
phosphodiesterase type 5 inhibitors
endothelin receptor antagonists
Online Access:http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-113903
http://nbn-resolving.de/urn:isbn:978-91-7601-376-2

Internet

http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-113903
http://nbn-resolving.de/urn:isbn:978-91-7601-376-2

Similar Items